[Use of a platelet anti-aggregant in evolutive glomerular nephropathies associated with regional intravascular coagulation disorder].
D000293:Adolescent; D000328:Adult; D001778:Blood Coagulation Disorders / Q000188:drug therapy* / Q000209:etiology; D002648:Child; D002908:Chronic Disease; D004341:Drug Evaluation; D005260:Female; D005921:Glomerulonephritis / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010080:Oxazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010973:Platelet Adhesiveness / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects; D013923:Thromboembolism / Q000517:prevention & control
D010080:Oxazoles
Impiego di un antiaggregante piastrinico nelle nefropatie glomerulari evolutive associate a quadri di coagulopatia intravascolare distrettuale.